Actitrexx Overview
- Year Founded
-
2016
- Status
-
Private
- Employees
-
11
- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$4.14M
- Investors
-
10
Actitrexx General Information
Description
Developer of a cell therapy technology designed for the treatment of patients after a stem cell transplant to prevent rejection reactions. The company's technology focuses on the development of clinical testing of cell therapeutics for the suppression of transplant rejection and autoimmunity, and the portfolio of cell therapy, enabling healthcare professionals to prevent the fatal consequences of rejection, significantly improving their quality of life, and also opening up to many therapy options.
Contact Information
Website
www.actitrexx.deCorporate Office
- Langenbeckstrasse 1, Building 401
- C/o University Medical Center Mainz, Johannes Gutenberg-University Mainz
- 55131 Mainz
- Germany
Corporate Office
- Langenbeckstrasse 1, Building 401
- C/o University Medical Center Mainz, Johannes Gutenberg-University Mainz
- 55131 Mainz
- Germany
Actitrexx Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Early Stage VC (Series A) | 30-Nov-2020 | $4.14M | Completed | Clinical Trials - Phase 1 | ||
| 3. Accelerator/Incubator | Completed | Startup | ||||
| 2. Grant | 20-Jul-2018 | $2.33K | Completed | Startup | ||
| 1. Grant | 01-Jan-2016 | $4.35M | Completed | Startup |
Actitrexx Comparisons
Industry
Financing
Details
Actitrexx Competitors (34)
One of Actitrexx’s 34 competitors is Centrose, a Venture Capital-Backed company based in Madison, WI.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Centrose | Venture Capital-Backed | Madison, WI | ||||
| Baliopharm | Venture Capital-Backed | Basel, Switzerland | ||||
| Sorrento Therapeutics | Formerly VC-backed | San Diego, CA | ||||
| Topas Therapeutics | Venture Capital-Backed | Hamburg, Germany | ||||
| Toleranzia | Private Equity-Backed | Gothenburg, Sweden |
Actitrexx Patents
Actitrexx Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4806433-A1 | Combination of immunomodulatory agent and activated treg for treating autoimmune and autoinflammatory diseases | Pending | 14-Mar-2025 | ||
| WO-2026190367-A1 | Combination of immunomodulatory agent and activated treg for treating autoimmune diseases | Pending | 14-Mar-2025 | ||
| EP-4806432-A1 | Combination of immunomodulatory agent and treg activator for the treatment of an autoimmune and autoinflammatory disease | Pending | 14-Mar-2025 | ||
| WO-2026190366-A1 | Combination of immunomodulatory agent and treg activator for the treatment of an autoimmune and autoinflammatory disease | Pending | 14-Mar-2025 | ||
| US-10729742-B2 | Screening method for the identification of agents capable of activating cd4+cd25+ regulatory t-cells through interactions with the hiv-1 gp120 binding site on cd4 | Active | 01-Feb-2007 | A61K38/162 |
Actitrexx Signals
Actitrexx Investors (10)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| High-Tech Gründerfonds | Venture Capital | Minority | ||
| Investitions- und Strukturbank Rheinland-Pfalz | Venture Capital | Minority | ||
| LBBW Venture Capital | Corporate Venture Capital | Minority | ||
| MediVentures | Venture Capital | Minority | ||
| Rheinland-Pfalz Fonds | Corporation | Minority |
Actitrexx FAQs
-
When was Actitrexx founded?
Actitrexx was founded in 2016.
-
Where is Actitrexx headquartered?
Actitrexx is headquartered in Mainz, Germany.
-
What is the size of Actitrexx?
Actitrexx has 11 total employees.
-
What industry is Actitrexx in?
Actitrexx’s primary industry is Drug Discovery.
-
Is Actitrexx a private or public company?
Actitrexx is a Private company.
-
What is Actitrexx’s current revenue?
The current revenue for Actitrexx is .
-
How much funding has Actitrexx raised over time?
Actitrexx has raised $4.14M.
-
Who are Actitrexx’s investors?
High-Tech Gründerfonds, Investitions- und Strukturbank Rheinland-Pfalz, LBBW Venture Capital, MediVentures, and Rheinland-Pfalz Fonds are 5 of 10 investors who have invested in Actitrexx.
-
Who are Actitrexx’s competitors?
Centrose, Baliopharm, Sorrento Therapeutics, Topas Therapeutics, and Toleranzia are some of the 34 competitors of Actitrexx.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process